上海口腔医学 ›› 2026, Vol. 35 ›› Issue (5): 503-507.doi: 10.19439/j.sjos.2026.05.010

• 论著 • 上一篇    下一篇

Er:YAG激光联合抗生素治疗儿童Ⅲ期C级牙周炎的临床疗效评价

蔡佳1, 江煜2   

  1. 1.青岛大学附属妇女儿童医院 口腔科,山东 青岛 266001;
    2.青岛市中医医院,青岛大学附属青岛市海慈医院 口腔科,山东 青岛 266011
  • 收稿日期:2025-06-13 修回日期:2025-07-24 发布日期:2026-11-05
  • 通讯作者: 江煜,E-mail: jywztg23@163.com
  • 作者简介:蔡佳(1983—),女,硕士,主治医师,E-mail: cjwztg23@163.com
  • 基金资助:
    山东省医药卫生科技项目(202308020420)

Evaluation of the clinical efficacy of Er:YAG laser combined with antibiotics in the treatment of children with stage Ⅲ grade C periodontitis

Cai Jia1, Jiang Yu2   

  1. 1. Department of Stomatology, Qingdao Women and Children's Hospital of Qingdao University. Qingdao 266001;
    2. Department of Stomatology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao Haici Hospital affiliated to Qingdao University. Qingdao 266011, Shandong Province, China
  • Received:2025-06-13 Revised:2025-07-24 Published:2026-11-05

摘要: 目的: 评价Er:YAG激光联合抗生素治疗儿童Ⅲ期C级牙周炎的临床疗效。方法: 选择2021年6月—2025年2月收治的94例Ⅲ期C级牙周炎患儿,采用随机数字表法分为对照组(n=47,机械清创+抗生素)和试验组(n=47,对照组基础上联合Er:YAG激光)。比较两组患儿的临床疗效、牙周指标[探诊深度(probing depth,PD)、临床附着丧失 (clinical attachment level,CAL)和菌斑指数(plaque index,PLI)]、血清炎症因子[白细胞介素1β (interleukin-1β,IL-1β)、肿瘤坏死因子α(tumor necrosis factor-α,TNF-α)和白细胞介素6 (interleukin-6,IL-6)]、探诊出血(bleeding on probing,BOP)阳性率、骨密度变化及不良反应发生情况。结果: 试验组患儿治疗总有效率为89.36%(42/47),显著高于对照组的70.21%(33/47)(P<0.05)。治疗后试验组患儿PD、CAL和PLI显著低于对照组(P<0.05);血清IL-1β、TNF-α和IL-6水平显著低于对照组(P<0.05)。试验组患儿BOP阳性率为14.89%(7/47),显著低于对照组的34.04%(16/31)(P<0.05);骨吸收量显著低于对照组,骨密度显著高于对照组(P<0.05)。结论: Er:YAG激光联合抗生素治疗可显著降低Ⅲ期C级牙周炎患儿的BOP阳性率,改善牙周炎症及骨密度,安全性良好。

关键词: Ⅲ期C级牙周炎, Er:YAG激光, 抗生素, BOP阳性率, 骨密度

Abstract: PURPOSE: To evaluate the clinical efficacy of Er:YAG laser combined with antibiotics in the treatment of children with stage Ⅲ grade C periodontitis. METHODS: A total of 94 children with stage Ⅲ grade C periodontitis admitted between June 2021 and February 2025 were randomly divided into control group (n=47, mechanical debridement + antibiotics) and experimental group (n=47, Er:YAG laser combined on the basis of the control group). Clinical efficacy, periodontal indicators [probing depth (PD), clinical attachment level (CAL) and plaque index (PLI)], serum inflammatory markers [interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)], positive rate of bleeding on probing (BOP), bone density changes and adverse events were compared. RESULTS: The total effective rate was significantly higher in the experimental group (89.36%, 42/47) than in the control group (70.21%, 33/47) (P<0.05). After treatment, PD, CAL and PLI were significantly lower in the experimental group (P<0.05). Serum levels of IL-1β, TNF-α and IL-6 were also reduced in the experimental group (P<0.05). The BOP-positive rate in the experimental group (14.89%, 7/47) was significantly lower than that in the control group (34.04%, 16/47) (P<0.05),bone resorption was significantly decreased, and bone density was significantly increased in the experimental group(P<0.05). CONCLUSIONS: Er:YAG laser combined with antibiotics can significantly reduces the BOP-positive rate, improves periodontal inflammation and bone density, and demonstrates good safety in children with stage Ⅲ grade C periodontitis.

Key words: Stage Ⅲ grade C periodontitis, Er:YAG laser, Antibiotics, BOP-positive rate, Bone density

中图分类号: